Christopher Belnap is a successful entrepreneur, company founder, and the Entrepreneur-in-Residence at the University of Luxembourg. He specializes in driving innovation in biotechnology and healthcare, with a proven history of building companies and forging strategic partnerships. With a Ph.D. in microbiology from the University of California, Berkeley, Christopher has an extensive scientific background in microbial ecology and microbiome systems. He founded and served as CEO of Resilient Biotics, a company that developed novel respiratory therapeutics. During his time there, he secured multiple rounds of funding and key partnerships to advance the company's products. Christopher will be a featured speaker at BioTechX Europe 2025, where he will discuss the future of healthcare and the transformative potential of AI combined with organ-on-a-chip systems.